NewsBite

Nick Coatsworth

January

Eli Lilly’s Mounjaro medication.

Price must be right to put obesity drug on the PBS

It is vital the gatekeepers of the scheme hold the line on the cost benefits of blockbuster drugs.

October 2024

The US Centers for Disease Contol rapidly became politicised.

The danger of COVID zealots has not passed

The proposed new Australian Centre for Disease Control is open to the same ideological capture that plagued its US counterpart.

September 2024

Federation Square sits deserted during Melbourne’s second-wave lockdown in August 2020. Some groups faced serious harm from the lockdowns.

A cure for disinformation that’s as bad as the disease

Well-meaning legislation to protect Australians from online lies could end up silencing legitimate public health questions as well.

May 2024

Only legitimate Ozempic will be allowed in Australia, which will reduce supply.

The war over Ozempic isn’t helping overweight Australians

The drug regulators’ decision to ban compounded weight loss drugs won’t help those suffering health complications from obesity.

March 2024

Why WFH is likely to be bad for your health

Instead of offering a holy grail of flexibility and work-life balance, what if WFH might lead us to an early grave by actually increasing stress and decreasing our fitness?

September 2023

Three big questions the COVID-19 commissioners must answer

To produce useful, future-focused outcomes the inquiry will need to adopt a penetrating and sometimes critical posture in answering core questions on pandemic response.

Original URL: https://www.afr.com/by/nick-coatsworth-p53728